Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations
Amarin Sponsors Multiple Scientific Presentations Scheduled for 2018 American College of Cardiology Annual Scientific Session & Expo Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Sponsors Multiple Scientific Presentations Scheduled for 2018 American College of Cardiology Annual Scientific Session & Expo
Amarin Announces Start of Final Clinical Site Visits in the REDUCE-IT Cardiovascular Outcomes Study Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Announces Start of Final Clinical Site Visits in the REDUCE-IT Cardiovascular Outcomes Study
Amarin Announces Closing of Underwriter's Purchase of Additional Shares Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Announces Closing of Underwriter's Purchase of Additional Shares
Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP) Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP)
Amarin Announces First Middle East Approval for Vascepa® Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Announces First Middle East Approval for Vascepa®
Amarin Commemorates National Triglycerides Day on March 28 Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Commemorates National Triglycerides Day on March 28
Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco Submitted by amarin on Tue, 02/06/2018 - 13:10 Home Read more about Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018 Submitted by amarin on Tue, 02/06/2018 - 13:10 Home Read more about Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018
